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SUMMARY 
The high-performance liquid chromatographic (HPLC) behaviour of basic 
pharmaceutical substances is strongly influenced by the type of column packing, the 
pH of the mobile phase and the concentration and type of buffer ions. This results in 
many choices to be made by the chromatographer. In order to assist the chromato- 
grapher, an expert system has been developed for the selection of initial HPLC 
conditions. For this purpose, HPLC data for about 600 basic compounds were used. 
These compounds belong to the class of CNS-active or cardiovascular drugs. 
On the basis of this knowledge, which was completed with literature data, rules 
were defined and a knowledge base was built. The knowledge was implemented in KES 
(Knowledge Engineering System), a mid-sized expert system shell which runs on an 
IBM-PC. The system asks for information with respect to the substance(s) to be 
analysed. This information is given in the form of a table of structural elements. The 
output of the system specifies the chromatographic characteristics which should be 
used, i.e., type of stationary phase, mobile phase composition, buffer pH, flow-rate 
and method of detection. 
INTRODUCTION 
The development of a new drug is a long and costly process. At the various 
stages, from the first synthesis of a new compound to drug monitoring in clinical 
studies and quality control of the finished product, analytical methods play an 
important role. Among the analytical methods used, high-performance liquid 
chromatography (HPLC) is most widely applied. HPLC is used to establish the purity 
of a drug candidate and to determine the drug in pharmaceutical formulations, in 
samples from stability testing and in pharmacokinetic and clinical studies. 
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Fig. 1. Outline of an integral expert system for method development in HPLC. The present paper concerns 
method selection (first guess), which is the first (highlighted) box. 
In the first step of drug development, a large number of chemical compounds are 
synthesized. Before these compounds are screened in pharmacological tests, they are 
subjected to HPLC analysis to check their purity. As most of these compounds are 
submitted for analysis only once, optimization of either the selectivity or the analysis 
time is not required. However, the “first guess” HPLC conditions should preferably 
result in capacity factors (k’) between 3 and 10 in order to obtain optimal resolution in 
an acceptable time. 
The choice of the initial HPLC conditions is the first step in method development 
(Fig. 1). The selection of these initial conditions requires specific knowledge and 
expertise. For example, several studies’ were directed to finding the relationship 
between chemical structure and chromatographic retention. However, the selection of 
the correct percentage of modifier in the mobile phase in order to obtain a certain 
retention is still an heuristic process. 
In recent years, expert systems have been proposed to advise the chromato- 
grapher. Varian was the first to announce work on expert systems in chromatography, 
in 1984. Under the acronym ECAT (Expert Chromatographic Assistance Team), the 
system has since been introduced in detail and explained2s3. 
Within ESPRIT (European Strategic Programme for Research and Develop- 
ment in Information Technology), a programme supported by the EEC, a large group 
of scientists is working on a project on the “Application of Expert Systems in the 
Chemical Analysis” (ESCA)4. The aim of this project is to demonstrate the 
applicability of expert systems in HPLC, particularly applied to pharmaceutical 
analysis. The project covers the whole field of method development5-7. The scheme 
shown in Fig. 1 became the basis of our work within ESCA. Based on this scheme, four 
different expert systems were developed. 
Other groups are also working on the applicability of expert systems in (liquid) 
chromatography8p12. This illustrates the broad interest of the industry and universities 
in these types of computer systems. One expert system, called LABEL13*14, has been 
developed for the selection of the initial HPLC method in pharmaceutical analysis. 
The system is suitable for a broad range of compounds, but only a cyanopropyl 
column is used. The knowledge of LABEL is, like the present expert system, also 
implemented in KES (Knowledge Engineering System; Software Architecture and 
Engineering, Arlington, VA, U.S.A.). 
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In this paper we present details of an expert system for the first step of method 
development in HPLC. 
SELECTION OF CHEMICAL AREA 
The expert system, called by us a “first guess” system, was developed in the first 
instance for the purity control of compounds in development at Organon Interna- 
tional. These compounds, which are submitted to a purity check, are generally fairly 
pure, having a total concentration of substance-related compounds of less than 5%. 
The polarity of these related compounds is usually close to that of the main substance. 
The strongly more polar and/or less polar compounds will generally be removed at an 
earlier stage, e.g., by (fractional) crystallization and, if still present, will be traced by 
thin-layer chromatography. Because, within one sample, only compounds with 
a limited range of polarities have to be analysed by HPLC, an expert system has been 
developed that predicts conditions for isocratic elution only. Further, the resolution 
obtainable, which is determined by the length of the column and the retention of the 
compound, is more important than the analysis time. Generally, we use a long column 
and a capacity factor (k’) between 3 and 10. 
Traditionally, chromatographers have encountered problems in the reversed- 
phase chromatography of basic nitrogen-containing substances. Among the undesir- 
able effects are severe tailing, band broadening and low plate numbers. In recent years 
we have carried out much work on the reversed-phase HPLC analysis of basic 
compounds which belong to the CNS-active drugs (drugs acting on the central nervous 
system) or cardiovascular drugs. Some typical examples are shown in Fig. 2. 
Generally, these drug molecules are small and contain one or more nitrogen 
atoms. Many of these nitrogen-containing compounds are basic and can be 
protonated. Important exceptions are the barbiturates. which are slightly acidic, and 
CH-CH2-CH,-N-(CH,)z 
Amitriptyline 
CO-CH,-CH,-CH,m N 
Haloperidol 
Mianserin 
OH 
(CH3)2-CH-CH2-O-CH2-CHm N 
,3 
Propranolol Bepridil 
Fig. 2. Some typical representatives of basic pharmaceutical compounds. 
258 R. HINDRIKS et al. 
amino acids, which are amphoteric. It is assumed that the protonated drugs (XH+) 
interact with the acidic free silanol sites (SiO-Naf) on the reversed-phase packing by 
an ion-exchange processi5,i6: 
XH’ + SiO-Na+ + Na+ + SiO-XHS 
As a result, the peaks of the basic solutes have a relatively broad and tailing shape. 
Basic drugs are extremely important for the pharmaceutical industry. Therefore, 
great attention has been paid to the often poor results of the reversed-phase HPLC of 
these compounds and many suggestions have been made for improving this17-19. 
Our extensive experience with the HPLC of basic drugs, together with literature 
data, form the knowledge base for this expert system. Elements from the knowledge 
base will be explained. Rules that have been derived from the knowledge are 
implemented in an expert system shell and this process is also outlined. 
SELECTION OF EXPERT SYSTEM SHELLS 
A large number of expert system shells (tools) are available today, and the 
number is still steadily growing. A useful possibility for classification of these tools is to 
divide them on the basis of the size of the tool, i.e., small, mid-size and large. An 
overview of the tools tested in ESCA is given in Table I. Small tools generally run on 
PCs whereas mid-size tools need expanded PCs or workstations. The large tools run 
only on large workstations. 
One of the aims of ESCA has been to select suitable tools for the project. This 
was done by judging the relevant aspects, such as ease of implementation, inference 
facilities, support facilities, price and possibility of running on a personal computer. 
Apart from Delphi 2 and MYLOG, the tools have all been developed in the 
U.S.A. Delphi 2 was apparently too small for the job. On the other hand, the large 
tools can be regarded as oversized for our purpose. Often they are less easy to explore 
by the knowledge engineers because of their large potential, and the high price can also 
be prohibitive. For us, the main disadvantage was the fact that these large tools cannot 
be run on a personal computer. The mid-size tools were clearly the best for our project. 
Within ESCA we chose Goldworks, KES and NExpert Object for further evaluation4. 
They all run on an IBM/PC and compatible systems. The knowledge is represented by 
TABLE I 
SOME EXPERT SYSTEM TOOLS INVESTIGATED WITHIN ESCA AND THEIR SIZE AND 
ORIGIN 
Name Size Origin 
Delphi 
Goldworks 
MYLOG 
KES 
NExpert Object 
KEE 
Knowledge Craft 
Small 
Medium 
Medium 
Medium 
Medium 
Large 
Large 
The Netherlands 
U.S.A. 
France 
U.S.A. 
U.S.A. 
U.S.A. 
U.S.A. 
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a set of rules. The selected systems offer backward and forward chaining as inference 
mechanisms. Goldworks and KES can also use frames and a network of frames can be 
built by defining relations between them, e.g., by inheritance. Goldworks also features 
pattern matching. External links to databases, spreadsheets and other external 
processes are provided. With respect to the userrknowledge engineer interface, 
Goldworks has the best facilities. 
Goldworks was tested for the method validation expert system7 and NExpert 
Object was used in the development of the system optimization expert system6. For the 
expert system which we describe here, we worked exclusively with KES (release 2.4), 
a tool which was already well known in Massart’s groupr3,i4 and which has been used 
for many applications. Moreover, KES matches closely our formulated selection 
criteria and was shown to be a very flexible tool. In the final phase of the ESPRIT 
project we shall evaluate the possibilities and limitations of the three shells. 
KNOWLEDGE BASE 
Before an expert system can be consulted, the knowledge base has to be tilled 
with rules by the knowledge engineer. In our case the most important input parameters 
are related to information on the chemical structure, chromatographic and chemical 
information, detector parameters and other information. 
Chemical structure information 
Information about the polarity of the sample component(s) is essential for the 
chromatographer. A relative measure that was introduced some years ago is the 
retention index (RI)“, which can be used to characterize the polarity of the molecule 
and to link the structure elements to some type of polarity descriptor. 
Numerous methods have been described for the determination of RI values2’. 
Throughout we used the method of Baker and Ma21, which is based on a homologous 
series of 2-ketoalkanes. Under strict conditions it was shown that the RI values are 
reasonably constant. RI values for 300 compounds in combination with chromato- 
graphic data on the purity analyses of more than 300 compounds were the basis of the 
knowledge. 
We chose to estimate the polarity of a given molecule on the basis of the presence 
of polar and apolar groups. Therefore, the molecular structure of the sample is an 
essential feature. The expert system has to calculate the polarity of a new compound 
from its structure and expresses the result as a percentage of organic modifier 
(methanol) in the mobile phase. Before this can be done, the structure is subdivided 
into fragments or structural elements. These elements are so defined that they can 
describe a structure in a simple and unambiguous manner. Examples of such elements 
are phenyl, methyl, hydroxyl and tertiary nitrogen. All initially selected structural 
elements are shown in Table II. As in QSAR (quantitative structure-activity 
relationship), each element can be linked to a fragment value22 or, as here, to 
a percentage of methanol. For apolar groups this is a positive contribution and for 
polar elements a negative contribution. 
The percentages listed in Table II are essentially derived from experimental data. 
As an example, one could chromatograph a drug molecule and an analogue having an 
additional methyl or hydroxyl group. By comparing the methanol percentages at the 
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TABLE II 
SOME STRUCTURAL ELEMENTS AND THEIR EFFECTS ON THE PREDICTED PERCENTAGE 
OF METHANOL AT pH 7.4 AND 4.0 
Structural element Methanol (%) 
pH 7.4 pH 4.0 
(1) 
(2) 
(3) 
(4) 
(5) 
(6) 
(7) 
(8) 
Phenyl, monosubstituted (C,H,) 
Phenyl, disubstituted (C,H,) 
Phenyl, trisubstttuted (C,H,) 
Cl on aromatic group 
Cl on aliphatic group 
(9) 
(10) 
OH on aromatic group 
OH on aliphatic group 
0 atom in ether. The oxygen positioned between: 
(a) two aromatic groups 
(b) an aromatic and an aliphatic group 
(c) two aliphatic groups 
0 atom in ketone. The carbon connected to the oxygen is positioned between: 
(a) two aromatic groups 
(b) an aromatic and an aliphatic group 
(c) two aliphatic groups 
S atom. The sulphur positioned between: 
(a) two aromatic groups 
(b) an aromatic and an aliphatic group 
(c) two aliphatic groups 
(11) Pyridine 
(12) CHJ 
(13) CHz 
(14) CH 
(15) C 
(16) 
(17) 
(18) 
N atom in ring plus double bond 
N atom in two rings 
Other N atoms: first one 
every next one 
+11 
+lO 
f9 
+7 
fl 
-2 
-10 
-5 
-5 
-10 
-5 -5 
-6 -6 
-10 -10 
f3 
+1 
-3 
+3 
+5 
f3 
f2 
+1 
-5 
0 
-5 
-5 
t11 
+10 
+9 
i-7 
+1 
-2 
-10 
-5 
-5 
-10 
+3 
+1 
-3 
-5 
+5 
+3 
+2 
fl 
-5 
0 
-30 
-5 
same k’, the contribution of that group can be derived for a given column. Using our 
large database, this calculation can be done fairly accurately. As can be seen from 
Table II, most fragment contributions are independent of the pH of the mobile phase. 
It can easily be understood that this is not the case for fragments that can be 
protonated. 
The percentage of organic modifier (methanol) can be calculated by adding up 
the fragment contributions together with a zero level. We determined experimentally 
the zero level for a NovaPak Cl8 column at 43% of methanol. In other words, 
methanol (%) = C (fragment contributions) + 43%. The same holds for a PBondapak 
Cl8 column, except that the zero level is 2% lower. 
For every new compound, the present prototype expert system needs a list of 
structural elements to calculate the polarity. Although in principle this is a simple task, 
errors are being made especially by workers who are not trained in “reading” 
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Input 
II 
Selection 
Stationary phase 
Cl8 CN 
Selection 
Column Size 
conventional microbore 
II 
Flow-rate 
Selection 
pH mobile phase 
7.4 4.0 
Selection 
detector 
Fig. 3. Method selection in the present expert system 
structures. Therefore, the number of structural elements is limited. On the other hand, 
in order to increase the applicability of the system, it is clear that the number of 
structural elements has to be increased. It was found that the number of structural 
elements shown in Table I is a good compromise between usability and applicability. 
For future developments, we are trying to implement a program that makes use of 
so-called connectivity tables. These tables are generated by advanced structure 
representation software programs, such as DARC (Telesystemes, Paris, France). 
Chromatographic information 
Part of the chromtographic knowledge is included in the method selection 
section of the expert system, as shown in Fig. 3. For most applications we routinely use 
tetramethylammonium phosphate buffer to block the free silanol sites on the 
reversed-phase material . I7 Methanol is preferred as the organic modilier. 
In our experience, a reversed-phase system provides the required selectivity for 
purity analysis of drugs. We use a cyanopropyl column for compounds containing 
quaternary nitrogen atoms and a C1 8 column for other basic compounds. The buffer 
pH of the mobile phase is merely dictated by the character of the separation. In 
addition to the chemical structure of the compound, other information can also be 
useful, such as related compounds that might be present and remaining products from 
the last step of the synthesis. We have observed that the selectivity for small lipophilic 
differences, e.g., for cis-trans isomers, is generally optimal at a pH between 7 and 8. 
Therefore, we prefer a high pH for separations that might be critical in this respect. 
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Detector parameters 
For a purity check of new compounds, it is important to detect all kind of 
by-products that can be expected, e.g., starting materials, related products from the 
synthesis and reagents. Normally, these products have different UV absorptivities. As 
they are often present in small amounts ( < 1 %), universal detection by an insensitive 
refractive index detector is impractical. A more practical solution is to use a UV 
detector (variable wavelength or diode-array) operating at a short wavelength 
(205-210 nm). Because most pharmaceutical compounds have at least some UV 
absorptivity, UV detection is the best compromise between a reasonable universal 
CHROMATOGRAPHIC SETUP 
- mobile phase system (RP; NP; IPC) 
- column 
- detection (W detector: RI detector: unknown) 
- flow rate (0.00 . . 5.00) 
- temperature (0 . . 70) 
FIRST TRIAL CHROMATOGRAPHIC SETUP 
is a CHROMATOGRAPHIC SETUP 
mobile phase system (RP; NP) [default: RP] 
column 
detection (W detector: RI detector] 
flow rate (0.2 or 0.3; 1.5 or 2.0) 
temperature (30) 
organic modifier 
buffer 
organic modifier 
basic solvent 
organic modifier 
PIG 
nature (TMA-phosphate) 
pH (4; 7.4) 
% {OO . . 100) 
ORGANIC MODIFIER 
- nature (methanol; acetonitrile; mixture) [default: methanol] 
- % (00 (default) . . 100) 
- % final (00 . . 100) 
MIXTURE 
- nature (methanol + acetonitrile) 
- % methanol (00 . . 100) 
- % acetonitrile (00 . . 100) 
BASIC SOLVENT 
- nature (hexane) 
- % (00 . . 100) 
PIG 
- nature (hexane sulphonate, heptane sulphonate, 
octane sulphonate) 
Fig. 4. Frame structure showing how the mobile phase is related to the chromatographic set-up. 
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detection method and good sensitivity. Provided that methanol of good quality is used, 
impurities at the 0.1% level can easily be detected. 
Other parameters 
Other characteristics of the sample molecule, which have been determined 
previously, can be very helpful for the chromatographer. One of the important 
characteristics of a drug molecule is its dissociation constant (pK). Initially, the expert 
system was in principle developed for basic Organon compounds with a pK, value 
between 4 and 10 (measured for the protonated drug). We are now investigating 
whether the system can also be applied to a broader range of pharmaceutical 
compounds. 
IMPLEMENTATION 
The implementation of the expert system was preceded by two important steps, 
the knowledge acquisition and the formalization of the knowledge. 
The knowledge acquisition was mainly done by interview, but other techniques 
were also used. Sometimes information was exchanged in written form. The results 
from this knowledge acquisition are that the important features in the domain are 
defined and the relationship between those features are determined. 
The next step in the process was to formalize the knowledge. This was done 
independently of the selected tool. A kind of series of frames was built. Some of these 
frames have one or more subframes which reflect part of the relationship between the 
frames. Different sets of rules were built to translate the complete relationship between 
the frames. Part of this structure is shown in Fig. 4 and an example of a rule group is 
shown in Fig. 5. Another way to formalize the knowledge is the use of state transition 
diagrams and data flow diagrams. The representation of the knowledge kept in this 
expert system is shown in Fig. 6 in a data flow diagram. After this formalization step, 
the real implementation of the prototype started. 
The selected tool is KES.PS (Software Architecture and Engineering, release 
2.4) which is written in C. The use of frames is not explicitly available in this tool, but 
by combining the classes (abstract objects, models on which attributes are defined) and 
Fl 
IF Column type = CONVENTIONAL 
andColumn. brand = novapak 
THEN flow rate = 1.5mllmln 
F2 
IF Column. type = CONVENTIONAL 
and Column. brand = mlcrobondapak 
THEN flow rate = 2mlimln 
F3 
IF Column. type = MICROBORE 
and Column. length = 1 OOmm 
and Column diameter = 2.1 mm 
THEN flow rate = 0.2mlimin 
F4 
IF Column. type = MICROBORE 
and Column. length = 2OOmm 
and Column. diameter = 2.1 mm 
THEN flow rate = 0.3ml/min 
Fig. 5. Rules showing how the flow-rate is determined 
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Fig. 6. Data flow diagram provided with input and output. 
the attributes (objects used to define characteristics and features of a problem), 
a frame-like structure can be built. 
After the definition of the attributes and the classes, the rules must be dehned in 
the rule section. Here the rules are listed that are used by a domain expert to infer 
a value for an attribute based on the values of other attributes. In KES it is impossible 
to define groups of rules. However, by defining to which class a rule is applicable the 
rules are more or less split up in rule groups. The next part in the knowledge base is the 
action section, where the order and the character of an end-user session are controlled. 
The knowledge base is guided by the action part to seek appropriate information and 
to inform the end-user about relevant pieces of information generated by the system. 
CONCLUSIONS AND FUTURE DEVELOPMENTS 
Reversed-phase HPLC of basic pharmaceuticals requires extensive experimental 
and theoretical expertise. Therefore, it was seen as a challenge to develop an expert 
system that can assist the chromatographer in the selection of initial HPLC conditions. 
The most difficult task proved to be to describe correctly and yet in a simple way 
the polarity of a sample molecule on the basis of its chemical structure. Our approach, 
viz., to divide the molecule into structural elements, proved to be successful, but also 
showed some limitations. 
On the basis of expert knowledge rules were formulated, which were imple- 
mented in KES. A prototype expert system showed its usefulness for the selection of 
initial HPLC conditions for the analysis of basic drugs. 
We are now working on an extension of this project in two directions: (i) to 
establish a second (or next) guess when the initially selected conditions proved to be 
not in the correct range, viz., a capacity factor between 3 and 10; and (ii) to use 
a computer program for structure representation such as DARC, and write an 
EXPERT SYSTEM FOR HPLC OF PHARMACEUTICALS 265 
additional computer program for it so that the subdivision of a chemical structure into 
defined fragments can be carried out by the computer. 
Work has also been planned to validate the implementation of the chemical 
knowledge and to evaluate the accuracy of the advice of the present expert system. 
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